Evidence map›Paper›PMID 37993778›Full record

ArticleBMC bioinformatics2023

MiREx: mRNA levels prediction from gene sequence and miRNA target knowledge.

Elena Pianfetti, Marta Lovino, Elisa Ficarra, Loredana Martignetti

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Elena PianfettiDepartment of Engineering, University of Modena and Reggio Emilia, Via Vivarelli 10/1, Modena, 41225, Italy.
Marta LovinoDepartment of Engineering, University of Modena and Reggio Emilia, Via Vivarelli 10/1, Modena, 41225, Italy. marta.lovino@unimore.it.
Elisa FicarraDepartment of Engineering, University of Modena and Reggio Emilia, Via Vivarelli 10/1, Modena, 41225, Italy.
Loredana MartignettiInstitut Curie, Rue d'Ulm 26, Paris, 75005, France. loredana.martignetti@curie.fr.
University of Modena and Reggio Emilia · ITInstitut Curie · FR

Funding

Horizon 2020 826121Horizon 2020 965193
6 · The paper itself

Abstract

Messenger RNA (mRNA) has an essential role in the protein production process. Predicting mRNA expression levels accurately is crucial for understanding gene regulation, and various models (statistical and neural network-based) have been developed for this purpose. A few models predict mRNA expression levels from the DNA sequence, exploiting the DNA sequence and gene features (e.g., number of exons/introns, gene length). Other models include information about long-range interaction molecules (i.e., enhancers/silencers) and transcriptional regulators as predictive features, such as transcription factors (TFs) and small RNAs (e.g., microRNAs - miRNAs). Recently, a convolutional neural network (CNN) model, called Xpresso, has been proposed for mRNA expression level prediction leveraging the promoter sequence and mRNAs' half-life features (gene features). To push forward the mRNA level prediction, we present miREx, a CNN-based tool that includes information about miRNA targets and expression levels in the model. Indeed, each miRNA can target specific genes, and the model exploits this information to guide the learning process. In detail, not all miRNAs are included, only a selected subset with the highest impact on the model. MiREx has been evaluated on four cancer primary sites from the genomics data commons (GDC) database: lung, kidney, breast, and corpus uteri. Results show that mRNA level prediction benefits from selected miRNA targets and expression information. Future model developments could include other transcriptional regulators or be trained with proteomics data to infer protein levels.

Indexed as

MicroRNAsGene Expression ProfilingGene Expression RegulationMirexRNA, MessengerTranscription FactorsMicroRNAsMirexRNA, MessengerTranscription FactorsCNNDNAGene expression levelsMiRNAsPromoterSequence

Identifiers

PMID37993778
PMCPMC10666312
OpenAlexW4388913006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.